[1]
Parth Mehra 2025. Implementation of the First Available Long-Acting HIV Medication (Cabotegravir/Rilpivirine) Into Routine Clinical Care. Kansas Journal of Medicine. 18, S3 (Sep. 2025), 26. DOI:https://doi.org/10.17161/kjm.vol18.24449.